Literature DB >> 17368460

Clinical and metabolic features of polycystic ovary syndrome.

Lin Li1, Dongzi Yang, Xiaoli Chen, Yaxiao Chen, Shuying Feng, Liangan Wang.   

Abstract

OBJECTIVE: To explore the clinical and metabolic features of Chinese women with polycystic ovary syndrome (PCOS).
METHODS: The clinical data of 273 Chinese women diagnosed as having PCOS were retrospectively studied.
RESULTS: Of these women 34.8% had hirsutism, 45.1% had acne, 94.1% had some menstrual abnormality, and 96.7% had typical appearances of polycystic ovaries on ultrasonographic examination. The prevalence of overweight women was 30.4%, and the prevalence of insulin resistance was 12.8% using the glucose to insulin ratio (GIR) and 21.6% using the homesostasis model assessment (HOMA). Body mass index was significantly correlated with fasting insulin level (r=0.50), GIR (r=0.37) and HOMA (r=0.53).
CONCLUSION: Menstrual abnormality and polycystic ovaries were the main clinical manifestations in this cohort of Chinese women with PCOS. The prevalence of hyperandrogenism, obesity, and insulin resistance was lower in this cohort than in women from other races with the same condition. Ethnic differences needs to be considered when studying the clinical and metabolic features of women with PCOS.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17368460     DOI: 10.1016/j.ijgo.2007.01.005

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  8 in total

1.  Elevated serum anti-mullerian hormone in adolescent and young adult Chinese patients with polycystic ovary syndrome.

Authors:  Lin Li; Xiaoli Chen; Yaqin Mo; Yaxiao Chen; Meiying Wenig; Dongzi Yang
Journal:  Wien Klin Wochenschr       Date:  2010-09-03       Impact factor: 1.704

2.  Clinical and Biochemical Characteristics of Polycystic Ovary Syndrome in Benghazi- Libya; A Retrospective study.

Authors:  Fi Najem; Rr Elmehdawi; Am Swalem
Journal:  Libyan J Med       Date:  2008-06-01       Impact factor: 1.657

3.  Anti-mullerian hormone as a diagnostic and prognostic tool for PCOS patients.

Authors:  Budi Wiweko; Mila Maidarti; M Dwi Priangga; Nadia Shafira; Darrell Fernando; Kanadi Sumapraja; Muharam Natadisastra; Andon Hestiantoro
Journal:  J Assist Reprod Genet       Date:  2014-08-14       Impact factor: 3.412

4.  Women's reproductive health in the Sakha Republic (Yakutia).

Authors:  Natalia I Douglas; Tatiana U Pavlova; Tatiana E Burtseva; Yana G Rad; Palmira G Petrova; Jon Ø Odland
Journal:  Int J Circumpolar Health       Date:  2014-10-30       Impact factor: 1.228

5.  Insulin resistance and obesity among infertile women with different polycystic ovary syndrome phenotypes.

Authors:  Moamar Al-Jefout; Nedal Alnawaiseh; Aiman Al-Qtaitat
Journal:  Sci Rep       Date:  2017-07-13       Impact factor: 4.379

6.  Polycystic ovary syndrome in Salvador, Brazil: a prevalence study in primary healthcare.

Authors:  Ligia Gabrielli; Estela M I Aquino
Journal:  Reprod Biol Endocrinol       Date:  2012-11-22       Impact factor: 5.211

7.  Changes in clinical and biochemical characteristics of polycystic ovary syndrome with advancing age.

Authors:  Sebastião Freitas de Medeiros; Márcia Marly Winck Yamamoto; Matheus Antônio Souto de Medeiros; Bruna Barcelo Barbosa; José Maria Soares; Edmund Chada Baracat
Journal:  Endocr Connect       Date:  2020-02       Impact factor: 3.335

8.  Cutaneous Manifestations and Hormonal Changes Among Polycystic Ovary Syndrome Patients at a Tertiary Care Center.

Authors:  Yara E Aljefri; Rana A Alahmadi; Rakan S Alajmi; Taif A Alkhamisi; Hadeel A Maaddawi; Ali A Alraddadi; Awadh M Alamri
Journal:  Cureus       Date:  2021-12-22
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.